Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Tirzepatide vs Nalmefene for Reducing Alcohol Consumption in Alcohol-Dependent Patients
jRCTs061250103Recruiting
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in alcohol dependence comparing Tirzepatide arm with Nalmefene arm (2 arms). Primary endpoint: heavy drinking days (HDD). Started Mar 2026; status: recruiting.
02
Drugs
tirzepatidenalmefene
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on jRCTs061250103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061250103.